You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
醫美概念股走強:興科蓉醫藥(6833.HK)發力暴漲37%創5個月新高
格隆匯 01-13 13:35
格隆匯1月13日丨今日港A兩地的醫美概念股集體走強,其中,港股市場的興科蓉醫藥(6833.HK)盤中一度發力大漲37.29%至0.405港元,股價創去年8月以來新高。公司是國內醫藥行業領先的營銷、推廣及渠道管理服務供貨商,是國際四大血製品巨頭之一奧克特琺瑪的獨家代理商,興科蓉醫藥在國內血製品市場具有較強的稀缺性和競爭力。值得注意的是,過去一年,興科蓉醫藥最大的看點是加速調整業務佈局策略,進一步深入醫美領域,持續開發醫美新產品,積極拓展業績新增長點,且在創新研發提速的同時,還將醫美佈局延申到下游業務,完整構建醫美全產業鏈模式。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account